Cargando…
Trans-sialidase-based vaccine candidate protects against Trypanosoma cruzi infection, not only inducing an effector immune response but also affecting cells with regulatory/suppressor phenotype
Prophylactic and/or therapeutic vaccines have an important potential to control Trypanosoma cruzi (T. cruzi)infection. The involvement of regulatory/suppressor immune cells after an immunization treatment and T. cruzi infection has never been addressed. Here we show that a new trans-sialidase-based...
Autores principales: | Prochetto, Estefanía, Roldán, Carolina, Bontempi, Iván A., Bertona, Daiana, Peverengo, Luz, Vicco, Miguel H., Rodeles, Luz M., Pérez, Ana R., Marcipar, Iván S., Cabrera, Gabriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601629/ https://www.ncbi.nlm.nih.gov/pubmed/28938533 http://dx.doi.org/10.18632/oncotarget.18217 |
Ejemplares similares
-
Targeting Myeloid-Derived Suppressor Cells to Enhance a Trans-Sialidase-Based Vaccine Against Trypanosoma cruzi
por: Gamba, Juan Cruz, et al.
Publicado: (2021) -
Functional Autoreactive Anti-β2 Adrenergic Antibodies May Contribute to Insulin Resistance Profile in Patients with Chronic Chagas Disease
por: Rodeles, Luz María, et al.
Publicado: (2021) -
Trypanosoma cruzi trans-sialidase and neuraminidase activities can be mediated by the same enzymes
Publicado: (1992) -
Role of Trypanosoma cruzi Trans-sialidase on the Escape from Host Immune Surveillance
por: Nardy, Ana F. F. R., et al.
Publicado: (2016) -
Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina
por: Rodeles, Luz María, et al.
Publicado: (2021)